Australia Cancer Diagnostics Market Size & Outlook
Australia cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Australia cancer diagnostics market highlights
- The Australia cancer diagnostics market generated a revenue of USD 1,817.4 million in 2023 and is expected to reach USD 3,361.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 1,817.4 million |
| Market revenue in 2030 | USD 3,361.5 million |
| Growth rate | 9.2% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,680.0 million by 2030.
Consumables was the largest segment with a revenue share of 59.91% in 2023. Horizon Databook has segmented the Australia cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
Australia’s cancer diagnostics market is expected to grow significantly due to research collaborations and favorable government initiatives. In May 2022, the Australian Cancer Research Foundation (ACRF) launched the Child Cancer Liquid Biopsy Program for children with cancer.
Under this program, simple blood tests provide information about changes in a child with cancer and evaluate the treatment. Similarly, in January 2022, the Australian government announced an investment of USD 10 million in medical research to identify innovative methods to enhance participation in the country’s programs for screening for bowel, breast, & cervical cancers.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia cancer diagnostics market size, by product, 2018-2030 (US$M)
Australia Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
